Publications by authors named "Alex Amoros"

Claim this Profile
P
Pulmonary impairment independently determines mortality in critically ill patients with acute-on-chronic liver failure.
Martin S Schulz, Jan Mengers, Wenyi Gu, Andreas Drolz, Philip G Ferstl, Alex Amoros

Liver Int· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rectal colonization by resistant bacteria increases the risk of infection by the colonizing strain in critically ill patients with cirrhosis.
Verónica Prado, María Hernández-Tejero, Marcus M Mücke, Francesc Marco, Wenyi Gu, Alex Amoros

J Hepatol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers of extracellular matrix formation are associated with acute-on-chronic liver failure.
Annarein J C Kerbert, Saurabh Gupta, Eman Alabsawy, Iwona Dobler, Ida Lønsmann, Àlex Amoros

JHEP Rep· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis.
Jonel Trebicka, Javier Fernandez, Maria Papp, Paolo Caraceni, Wim Laleman, Alex Amoros

J Hepatol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved prediction of mortality by combinations of inflammatory markers and standard clinical scores in patients with acute-on-chronic liver failure and acute decompensation.
Henning Grønbaek, Holger Jon Møller, Faouzi Saliba, Stefan Zeuzem, Agustin Albillos, Alex Amoros

J Gastroenterol Hepatol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted lipidomics reveals extensive changes in circulating lipid mediators in patients with acutely decompensated cirrhosis.
Cristina López-Vicario, Antonio Checa, Arantxa Urdangarin, Ferran Aguilar, José Alcaraz-Quiles

J Hepatol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology.
Jonel Trebicka, Javier Fernandez, Maria Papp, Paolo Caraceni, Wim Laleman, Alex Amoros

J Hepatol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis.
Jonel Trebicka, Alex Amoros, Carla Pitarch, Esther Titos, José Alcaraz-Quiles

Front Immunol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HDL-related biomarkers are robust predictors of survival in patients with chronic liver failure.
Markus Trieb, Florian Rainer, Vanessa Stadlbauer, Philipp Douschan, Angela Horvath

J Hepatol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis.
Javier Fernández, Paolo Angeli, Jonel Trebicka, Manuela Merli, Thierry Gustot

Clin Gastroenterol Hepatol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic variants of innate immunity receptors are associated with mortality in cirrhotic patients with bacterial infection.
Jelte J Schaapman, Àlex Amoros, Johan J van der Reijden, Wim Laleman, Stefan Zeuzem

Liver Int· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis.
Javier Fernández, Joan Clària, Alex Amorós, Ferrán Aguilar, Miriam Castro

Gastroenterology· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orchestration of Tryptophan-Kynurenine Pathway, Acute Decompensation, and Acute-on-Chronic Liver Failure in Cirrhosis.
Joan Clària, Richard Moreau, François Fenaille, Alex Amorós, Christophe Junot

Hepatology· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe.
Javier Fernández, Verónica Prado, Jonel Trebicka, Alex Amoros, Thierry Gustot

J Hepatol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coagulation Failure in Patients With Acute-on-Chronic Liver Failure and Decompensated Cirrhosis: Beyond the International Normalized Ratio.
Annabel Blasi, Andrea Calvo, Verónica Prado, Enric Reverter, Juan Carlos Reverter, Alex Amoros

Hepatology· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome.
Salvatore Piano, Hartmut H Schmidt, Xavier Ariza, Alex Amoros, Antonietta Romano

Clin Gastroenterol Hepatol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis.
Javier Fernández, Juan Acevedo, Reiner Wiest, Thierry Gustot, Alex Amoros

Gut· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell death markers in patients with cirrhosis and acute decompensation.
Stewart Macdonald, Fausto Andreola, Patrik Bachtiger, Alex Amoros, Marco Pavesi

Hepatology· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure.
Joan Clària, Rudolf E Stauber, Minneke J Coenraad, Richard Moreau, Rajiv Jalan

Hepatology· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of C-reactive protein in cirrhosis: external validation from the CANONIC cohort.
Jean-Paul Cervoni, Àlex Amorós, Rafael Bañares, Jose Luis Montero, German Soriano

Eur J Gastroenterol Hepatol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics, Diagnosis and Prognosis of Acute-on-Chronic Liver Failure in Cirrhosis Associated to Hepatitis B.
Hai Li, Liu-Ying Chen, Nan-Nan Zhang, Shu-Ting Li, Bo Zeng

Sci Rep· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure.
Rajiv Jalan, Marco Pavesi, Faouzi Saliba, Alex Amorós, Javier Fernandez

J Hepatol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure.
Rajiv Jalan, Faouzi Saliba, Marco Pavesi, Alex Amoros, Richard Moreau

J Hepatol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF).
Juan Cordoba, Meritxell Ventura-Cots, Macarena Simón-Talero, Àlex Amorós, Marco Pavesi

J Hepatol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of two pretransplant predictive models and a flexible HCT-CI using different cut off points to determine low-, intermediate-, and high-risk groups: the flexible HCT-CI Is the best predictor of NRM and OS in a population of patients undergoing allo-RIC.
Pere Barba, Jose Luis Piñana, Rodrigo Martino, David Valcárcel, Alex Amorós

Biol Blood Marrow Transplant· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis